Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Polycystic Ovarian Syndrome: early-phase trial registry

A small indexed set (5 trials) with no open enrollment listed right now.

Corpus placement: #3,391 of 28,707 conditions by registered trial count.

5 US clinical trials · none currently recruiting · #3,391 of 28,707 conditions by registered trial count

Polycystic Ovarian Syndrome: 5 US clinical trials tracked, none currently recruiting.

Polycystic Ovarian Syndrome is the subject of 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is National Aeronautics and Space Administration, running 1 of these trials.

Enrollment posture brief

Registry condition polycystic-ovarian-syndrome

OPEN 0 | RECR 0% | LATE 0 | EARLY 1 | RANK #3391 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Polycystic Ovarian Syndr (th…0%
Open-enrollment share among volume-matched conditions near Polycystic Ovarian Syndrome

Polycystic Ovarian Syndrome has no open enrollment in this registry pull (5 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Polycystic Ovarian Syndrome on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Polycystic Ovarian Syndrome is recruiting below its size-band peers.

    0 of 5 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Polycystic Ovarian Syndrome research.

    National Aeronautics and Space Administration accounts for 1 of 5 trials (20%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Most Polycystic Ovarian Syndrome trials plan to enrol fewer than 100 people.

    Median target enrolment is 27 among the 5 trials that report a genuine target (sentinel values excluded). 5 of those (100%) plan for fewer than 100 participants.

  4. Polycystic Ovarian Syndrome splits between interventional and observational designs.

    3 interventional and 2 observational studies make up this index (60% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11

Phase Distribution

PhaseTrial count
Phase 1 1

Named interventions

Most-linked intervention names on Polycystic Ovarian Syndrome records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Soybean Oil Dietary supplement
1 trials
Flax Seed Oil Dietary supplement
1 trials
Endometrin (progesterone 100mg vaginal inserts) Drug
1 trials
Essential Amino Acid (EAA) Supplement Dietary supplement
1 trials
Birth control plus Brevail Drug
1 trials
Birth control Drug
1 trials
Fish Oil Dietary supplement
1 trials
Metformin Drug
1 trials

US sites by state

Facility locations filed on Polycystic Ovarian Syndrome trials. A trial with sites in several states counts in each.

Minnesota 1 trials
Kansas 1 trials
Connecticut 1 trials
Colorado 1 trials
California 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Polycystic Ovarian Syndrome page

5 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Polycystic Ovarian Syndrome condition card totals 5 registered trials; most-linked intervention Soybean Oil; top US site state Minnesota. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.